Medical City Dallas is a hospital located at 7777 Forest Lane, just west of North Central Expressway, in north Dallas, Texas. It is operated by Hospital Corporation of America

There are 876 beds in Medical City Dallas Hospital.

During the past decade, Medical City Dallas Hospital conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 102 clinical trials were completed, i.e. on average, 134.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 34 clinical trials were completed. i.e. 125.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical City Dallas Hospital" #1 sponsor was "Children's Oncology Group" with 130 trials, followed by "National Cancer Institute (NCI)" with 62 trials sponsored, "Edwards Lifesciences" with 12 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "Boston Scientific Corporation" with 9 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical City Dallas Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 161 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Children's Oncology Group" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Medical City Dallas Hospital" are "Leukemia" (27 trials), "Recurrent Neuroblastoma" (21 trials), "Sarcoma" (20 trials), "Recurrent Osteosarcoma" (17 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Medical City Dallas Hospital" in a lesser frequency.

Most popular intervention types in "Medical City Dallas Hospital" are "Drug" (198 trials), "Other" (104 trials), "Biological" (93 trials), "Procedure" (77 trials) and "Radiation" (73 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "Cyclophosphamide" (42 trials), "cyclophosphamide" (40 trials), "Vincristine Sulfate" (34 trials) and "filgrastim" (32 trials). Other intervention names were less common.

The vast majority of trials in "Medical City Dallas Hospital" are 268 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Medical City Dallas Hospital". undefined are not yet recruiting, 39 are recruiting, 69 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 156 completed trials in Medical City Dallas Hospital, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Medical City Dallas Hospital, 7 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 30 trials that are defined as “Not Applicable".

Medical City Dallas Hospital has several departments that took part in Clinical trials: "Medical City Children's Hospital" - 10 trials, "Medical City Denton" - 9 trials, "Center for Oncology Research and Treatment, Medical City Hospital" - 6 trials